who is not a good candidate for semaglutide The Firm Medspa Who Should Not Take Semaglutide?

At 1 mg weekly, semaglutide provides robust GLP-1 receptor agonism, with clinically significant reductions in HbA1c, body weight, and cardiovascular risk markers

I heard there are permanent and semi-permanent lip filler solutions like silicone, why not just do silicone instead of getting injected every year

doi: 10.1210/jc.2018-00070 20 SeinoYTerauchiYOsonoiTYabeDAbeNNishidaTet al

They engage with other conditions like diabetes quicker and might cause issues following inappropriate administration

Detailed patient instructions reduce those unnecessary follow-up questions

Understanding the medication's actual effects on digestive function, safety considerations, and management of gastrointestinal side effects is essential for clinicians prescribing this increasingly common therapy